+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Children's Drug Resistance Testing Market - Global Forecast 2026-2032- Product Image
Children's Drug Resistance Testing Market - Global Forecast 2026-2032- Product Image
Sale

Children's Drug Resistance Testing Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142657
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Children's Drug Resistance Testing Market is projected to reach USD 148.67 Million in 2026. It is expected to continue growing at a CAGR of 7.28%, reaching USD 225.64 Million by 2032.

Children’s Drug Resistance Testing: Executive Summary

Children’s drug resistance testing supports the selection and adjustment of therapies when infectious organisms may not respond to standard treatment. In pediatric care, testing must account for age, specimen volume, disease presentation, prior treatment, and the need to deliver clinically actionable results quickly. The field therefore connects laboratory diagnostics, antimicrobial stewardship, pediatric infectious-disease management, public-health surveillance, and caregiver communication.

Pediatric Care Is Shifting Toward Faster, More Targeted Resistance Detection

The landscape is being reshaped by antimicrobial resistance, greater attention to treatment failure, and demand for diagnostic pathways that reduce avoidable exposure to ineffective medicines. Molecular assays can identify resistance-associated markers rapidly, while culture-based methods remain important for phenotypic confirmation and susceptibility characterization. Implementation challenges include limited pediatric specimens, uneven laboratory capacity, quality assurance requirements, reimbursement constraints, and the need to interpret results alongside clinical history rather than in isolation.

Artificial Intelligence Is Strengthening Interpretation and Laboratory Operations

Artificial intelligence can support resistance testing by prioritizing specimens, flagging discordant results, interpreting complex molecular patterns, and identifying patients who may benefit from confirmatory testing. It can also improve laboratory workflow through automated quality checks, workload allocation, and surveillance dashboards. Safe adoption requires representative pediatric data, transparent validation, clinician oversight, cybersecurity, and controls against automation bias. AI should augment, not replace, microbiological judgment and stewardship decisions.

Regional Insights: Capacity and Access Remain Uneven

North America generally combines advanced pediatric laboratories with established stewardship infrastructure, although access and reimbursement can vary. Europe emphasizes coordinated surveillance, quality standards, and cross-border comparability, while implementation differs among health systems. Asia-Pacific includes highly developed laboratory networks alongside settings where specimen transport and testing access remain constrained. Latin America faces variation in laboratory resources, referral pathways, and continuity of care. The Middle East is expanding specialized diagnostic capacity but encounters differences in infrastructure and workforce availability. Africa often prioritizes decentralization, reliable supply chains, workforce development, and integration with broader infectious-disease programs.

Group Insights: Alliances Can Improve Standards and Interoperability

ASEAN cooperation can help address cross-border surveillance, laboratory-network development, and shared pediatric protocols. BRICS collaboration may support research partnerships, reference-laboratory capacity, and affordable access to validated methods. The European Union benefits from harmonized surveillance and quality frameworks, while the G7 can advance innovation, preparedness, and responsible data-sharing practices. GCC systems can coordinate specialized services, procurement, and referral networks. NATO members may benefit from interoperable surveillance and laboratory preparedness approaches relevant to health security, while maintaining civilian clinical governance and patient privacy.

Country Insights: National Priorities Differ Across Pediatric Testing Systems

Australia emphasizes coordinated public-health laboratories and geographically responsive access. Brazil’s priorities include strengthening regional laboratory networks and referral pathways. Canada must address distance, Indigenous and rural access, and system integration. China is focused on scale, laboratory modernization, and standardized clinical application. France, Germany, Italy, and Spain operate within structured European health systems while managing regional variation and stewardship needs. India faces substantial diversity in laboratory access and benefits from tiered testing and surveillance. Japan and South Korea combine advanced technology adoption with strong quality expectations. Mexico continues to need improved continuity between clinical services and diagnostic laboratories. Russia’s priorities include laboratory resilience, standardized practices, and access across a large territory. The United Kingdom emphasizes coordinated guidance, surveillance, and stewardship. The United States combines sophisticated testing capacity with substantial variation in access, payer coverage, and institutional practice.

Action Priorities for Leaders: Build Reliable, Clinically Integrated Testing

Industry leaders should first define pediatric use cases in which resistance results will change treatment decisions, then align assay selection with specimen realities and turnaround-time requirements. They should establish tiered networks linking local collection sites to qualified referral laboratories, invest in external quality assessment, and create clear escalation pathways for inconclusive results. Partnerships with clinicians, microbiologists, pharmacists, public-health agencies, and caregivers can improve adoption. Leaders should also implement interoperable reporting, protect sensitive pediatric data, validate AI tools prospectively, and measure outcomes such as time to effective therapy, repeat testing, inappropriate antimicrobial exposure, and equity of access.

Research Methodology: Evidence-Based Review of Pediatric Resistance Testing

This executive summary uses a structured qualitative review of the children’s drug resistance testing domain. The approach considers peer-reviewed clinical and laboratory evidence, public-health guidance, antimicrobial-resistance surveillance practices, diagnostic-performance principles, pediatric workflow constraints, and regional health-system factors. Findings are synthesized thematically across technology, implementation, geography, stakeholder groups, and national systems. Claims are limited to established or broadly documented patterns; no market estimates, market sizing, market shares, forecasts, or company-specific assessments are included.

Conclusion: Faster Results Must Be Matched With Stronger Pediatric Systems

Children’s drug resistance testing is most valuable when it produces reliable, interpretable information that reaches the treating team quickly and informs a specific clinical decision. Molecular innovation and AI can improve speed, scale, and consistency, but their benefits depend on specimen quality, confirmatory methods, trained personnel, equitable access, and stewardship integration. Sustainable progress will require coordinated laboratory networks, interoperable surveillance, pediatric-focused validation, and governance that keeps patient safety at the center.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Children's Drug Resistance Testing Market, by Test Method
7.1. Introduction
7.2. Genotypic Testing
7.2.1. Next Generation Sequencing
7.2.2. Sanger Sequencing
7.3. Phenotypic Testing
7.3.1. Growth Inhibition Assay
7.3.2. Reporter Virus Assay
8. Children's Drug Resistance Testing Market, by Pathogen Type
8.1. Introduction
8.2. Bacterial
8.2.1. Mycobacterium Tuberculosis
8.2.2. Staphylococcus Aureus
8.3. Fungal
8.4. Parasitic
8.5. Viral
8.5.1. Hepatitis B Virus
8.5.2. Hepatitis C Virus
8.5.3. Hiv
9. Children's Drug Resistance Testing Market, by Sample Type
9.1. Introduction
9.2. Blood Plasma
9.3. Tissue Biopsy
9.4. Whole Blood
10. Children's Drug Resistance Testing Market, by Age Group
10.1. Introduction
10.2. Adolescents
10.3. Early Childhood
10.4. Infants
10.5. Middle Childhood
10.6. Neonates
11. Children's Drug Resistance Testing Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Hospital Laboratories
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Pharmaceutical Companies
11.5. Reference Laboratories
12. Children's Drug Resistance Testing Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Children's Drug Resistance Testing Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Children's Drug Resistance Testing Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Molecular Inc.
16.2. Accelerate Diagnostics, Inc.
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. Danaher Corporation
16.6. Hologic, Inc.
16.7. Medtronic plc
16.8. QIAGEN N.V.
16.9. Roche Diagnostics International AG
16.10. Siemens Healthineers AG
16.11. Stryker Corporation
16.12. Teleflex Incorporated
16.13. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Children's Drug Resistance Testing Market, Years Considered for the Study
FIGURE 2. Global Children's Drug Resistance Testing Market, Research Design
FIGURE 3. Global Children's Drug Resistance Testing Market, Research Framework
FIGURE 4. Global Children's Drug Resistance Testing Market, Data Triangulation
FIGURE 5. Global Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Children's Drug Resistance Testing Market Size, by Test Method, 2025 vs 2032 (%)
FIGURE 7. Global Children's Drug Resistance Testing Market Size, by Test Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Children's Drug Resistance Testing Market Size, by Pathogen Type, 2025 vs 2032 (%)
FIGURE 9. Global Children's Drug Resistance Testing Market Size, by Pathogen Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Children's Drug Resistance Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Children's Drug Resistance Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Children's Drug Resistance Testing Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 13. Global Children's Drug Resistance Testing Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Children's Drug Resistance Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Children's Drug Resistance Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Children's Drug Resistance Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Children's Drug Resistance Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Children's Drug Resistance Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Children's Drug Resistance Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Children's Drug Resistance Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Children's Drug Resistance Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Children's Drug Resistance Testing Market Segmentation & Coverage
TABLE 2. Global Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 4. Global Genotypic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Genotypic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Genotypic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Phenotypic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Phenotypic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Phenotypic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Growth Inhibition Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Growth Inhibition Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Growth Inhibition Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Reporter Virus Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Reporter Virus Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Reporter Virus Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 23. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Mycobacterium Tuberculosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Mycobacterium Tuberculosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Mycobacterium Tuberculosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Staphylococcus Aureus Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Staphylococcus Aureus Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Staphylococcus Aureus Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Hepatitis B Virus Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Hepatitis B Virus Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Hepatitis B Virus Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hepatitis C Virus Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hepatitis C Virus Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hepatitis C Virus Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hiv Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hiv Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hiv Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 51. Global Blood Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Blood Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Blood Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Tissue Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Tissue Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Tissue Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 61. Global Adolescents Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Adolescents Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Adolescents Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Early Childhood Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Early Childhood Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Early Childhood Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Middle Childhood Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Middle Childhood Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Middle Childhood Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Neonates Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Neonates Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Neonates Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 107. North America Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. North America Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 109. North America Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 110. North America Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 111. North America Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 112. North America Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 113. North America Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 114. North America Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 115. North America Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 116. North America Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. North America Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 118. Latin America Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Latin America Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 120. Latin America Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 121. Latin America Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 122. Latin America Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 123. Latin America Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 124. Latin America Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 125. Latin America Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 126. Latin America Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 127. Latin America Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Latin America Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 129. Europe Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Europe Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 131. Europe Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 132. Europe Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 133. Europe Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 134. Europe Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 135. Europe Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 136. Europe Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 137. Europe Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 138. Europe Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Europe Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 140. Middle East Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Middle East Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 142. Middle East Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 143. Middle East Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 144. Middle East Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 145. Middle East Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 146. Middle East Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 147. Middle East Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 148. Middle East Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 149. Middle East Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Middle East Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 151. Africa Children's Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Africa Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 153. Africa Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 154. Africa Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 155. Africa Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 156. Africa Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 157. Africa Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 158. Africa Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 159. Africa Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 160. Africa Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Africa Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 162. Global Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 165. ASEAN Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 166. ASEAN Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 167. ASEAN Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 168. ASEAN Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 169. ASEAN Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 170. ASEAN Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 171. ASEAN Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 172. ASEAN Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. ASEAN Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 174. GCC Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. GCC Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 176. GCC Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 177. GCC Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 178. GCC Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 179. GCC Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 180. GCC Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 181. GCC Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 182. GCC Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 183. GCC Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. GCC Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 185. European Union Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. European Union Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 187. European Union Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 188. European Union Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 189. European Union Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 190. European Union Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 191. European Union Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 192. European Union Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 193. European Union Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 194. European Union Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. European Union Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 196. BRICS Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. BRICS Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 198. BRICS Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 199. BRICS Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 200. BRICS Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 201. BRICS Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 202. BRICS Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 203. BRICS Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 204. BRICS Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 205. BRICS Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. BRICS Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 207. G7 Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. G7 Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 209. G7 Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 210. G7 Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 211. G7 Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 212. G7 Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 213. G7 Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 214. G7 Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 215. G7 Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 216. G7 Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. G7 Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 218. NATO Children's Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. NATO Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 220. NATO Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 221. NATO Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 222. NATO Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 223. NATO Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 224. NATO Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 225. NATO Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 226. NATO Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 227. NATO Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. NATO Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 229. Global Children's Drug Resistance Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. United States Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 231. United States Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 232. United States Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 233. United States Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 234. United States Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 235. United States Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 236. United States Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 237. United States Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 238. United States Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 239. United States Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. United States Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 241. Canada Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 242. Canada Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 243. Canada Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 244. Canada Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 245. Canada Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 246. Canada Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 247. Canada Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 248. Canada Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 249. Canada Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 250. Canada Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Canada Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 252. Mexico Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 253. Mexico Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 254. Mexico Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 255. Mexico Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 256. Mexico Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 257. Mexico Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 258. Mexico Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 259. Mexico Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 260. Mexico Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 261. Mexico Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Mexico Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 263. Brazil Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 264. Brazil Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 265. Brazil Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 266. Brazil Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 267. Brazil Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 268. Brazil Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 269. Brazil Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 270. Brazil Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 271. Brazil Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 272. Brazil Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Brazil Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 274. United Kingdom Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 275. United Kingdom Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 276. United Kingdom Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 277. United Kingdom Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 278. United Kingdom Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 279. United Kingdom Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 280. United Kingdom Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 281. United Kingdom Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 282. United Kingdom Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 283. United Kingdom Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. United Kingdom Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 285. Germany Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 286. Germany Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 287. Germany Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 288. Germany Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 289. Germany Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 290. Germany Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 291. Germany Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 292. Germany Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 293. Germany Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 294. Germany Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Germany Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 296. France Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 297. France Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 298. France Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 299. France Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 300. France Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 301. France Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 302. France Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 303. France Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 304. France Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 305. France Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. France Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 307. Russia Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 308. Russia Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 309. Russia Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 310. Russia Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 311. Russia Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 312. Russia Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 313. Russia Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 314. Russia Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 315. Russia Children's Drug Resistance Testing Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 316. Russia Children's Drug Resistance Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Russia Children's Drug Resistance Testing Market Size, by Hospital Laboratories, 2017-2032 (USD Million)
TABLE 318. Italy Children's Drug Resistance Testing Market Size, 2017-2032 (USD Million)
TABLE 319. Italy Children's Drug Resistance Testing Market Size, by Test Method, 2017-2032 (USD Million)
TABLE 320. Italy Children's Drug Resistance Testing Market Size, by Genotypic Testing, 2017-2032 (USD Million)
TABLE 321. Italy Children's Drug Resistance Testing Market Size, by Phenotypic Testing, 2017-2032 (USD Million)
TABLE 322. Italy Children's Drug Resistance Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 323. Italy Children's Drug Resistance Testing Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 324. Italy Children's Drug Resistance Testing Market Size, by Viral, 2017-2032 (USD Million)
TABLE 325. Italy Children's Drug Resistance Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 326. Italy Children's Drug Resistance Testing Market S

Companies Mentioned

  • Abbott Molecular Inc.
  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Medtronic plc
  • QIAGEN N.V.
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Antimicrobial Resistance Diagnostic Market - Global Forecast 2026-2032 - Product Image

Antimicrobial Resistance Diagnostic Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Pneumococcal Testing Market - Global Forecast 2026-2032 - Product Image

Pneumococcal Testing Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Report 2026 - Product Image

Antimicrobial Resistance Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Bacterial Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bacterial Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.